Cardinal Health, Inc. $CAH Shares Bought by Rakuten Investment Management Inc.

Rakuten Investment Management Inc. lifted its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 9.1% during the 3rd quarter, Holdings Channel.com reports. The firm owned 41,851 shares of the company’s stock after purchasing an additional 3,480 shares during the period. Rakuten Investment Management Inc.’s holdings in Cardinal Health were worth $9,371,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in CAH. Downshift Financial LLC raised its holdings in shares of Cardinal Health by 3,666.7% in the third quarter. Downshift Financial LLC now owns 113 shares of the company’s stock valued at $25,000 after buying an additional 110 shares during the last quarter. Maryland Capital Advisors Inc. grew its holdings in Cardinal Health by 12,600.0% during the 3rd quarter. Maryland Capital Advisors Inc. now owns 127 shares of the company’s stock worth $28,000 after acquiring an additional 126 shares during the last quarter. Investors Research Corp bought a new stake in Cardinal Health during the 2nd quarter worth about $29,000. Allied Private Wealth LLC bought a new stake in Cardinal Health during the 2nd quarter worth about $30,000. Finally, Brown Lisle Cummings Inc. increased its position in Cardinal Health by 1,562.5% in the 3rd quarter. Brown Lisle Cummings Inc. now owns 133 shares of the company’s stock valued at $30,000 after acquiring an additional 125 shares in the last quarter. 87.17% of the stock is currently owned by institutional investors and hedge funds.

More Cardinal Health News

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Adjusted EPS was $3.26, above the roughly $2.94 analyst consensus and up 28% year over year. Revenue rose 5% to $67.5 billion, also topping expectations. Cardinal Health Q1 results and outlook
• Positive Sentiment: Management raised fiscal 2027 adjusted EPS guidance to $12.80–$13.00, signaling confidence in continued growth. Robust pharmaceutical sales helped drive the quarter. Q1 earnings beat on pharmaceutical strength
• Positive Sentiment: Cardinal completed a $500 million share-repurchase program during the quarter. The results also drew favorable analyst attention, including a price-target increase. Analyst raises price target
• Neutral Sentiment: The shares also advanced while the broader market was under pressure, suggesting the earnings and guidance news were a company-specific catalyst. Cardinal gains amid broader market declines
• Negative Sentiment: Management noted modest commodity and petroleum-related pressure in medical distribution, a potential headwind against otherwise healthy demand. Demand and commodity pressures

Cardinal Health Stock Up 2.4%

Shares of CAH opened at $268.10 on Friday. Cardinal Health, Inc. has a 12-month low of $180.45 and a 12-month high of $286.29. The firm has a market capitalization of $62.08 billion, a PE ratio of 37.08, a price-to-earnings-growth ratio of 1.57 and a beta of 0.53. The stock’s fifty day simple moving average is $239.73 and its 200-day simple moving average is $223.24.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings data on Thursday, November 5th. The company reported $3.26 EPS for the quarter, topping analysts’ consensus estimates of $2.94 by $0.32. The firm had revenue of $67.51 billion during the quarter, compared to analyst estimates of $66.67 billion. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%. The company’s revenue was up 5.5% on a year-over-year basis. During the same period last year, the company earned $2.55 earnings per share. Analysts anticipate that Cardinal Health, Inc. will post 12.55 EPS for the current year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st were paid a $0.5158 dividend. This represents a $2.06 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend was Thursday, October 1st. Cardinal Health’s dividend payout ratio (DPR) is 28.49%.

Insider Buying and Selling

In other news, insider Michelle Greene sold 11,650 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $235.72, for a total transaction of $2,746,138.00. Following the completion of the sale, the insider owned 10,330 shares in the company, valued at $2,434,987.60. The trade was a 53.00% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Stephen Mason sold 35,000 shares of Cardinal Health stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $236.40, for a total transaction of $8,274,000.00. Following the sale, the chief executive officer owned 18,061 shares of the company’s stock, valued at approximately $4,269,620.40. This represents a 65.96% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 210,271 shares of company stock worth $49,626,657. 0.12% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

CAH has been the subject of a number of research analyst reports. Barclays boosted their target price on shares of Cardinal Health from $258.00 to $275.00 and gave the stock an “overweight” rating in a research note on Thursday, August 13th. UBS Group upped their target price on shares of Cardinal Health from $280.00 to $295.00 and gave the stock a “buy” rating in a research report on Friday, October 16th. JPMorgan Chase & Co. increased their price target on shares of Cardinal Health from $215.00 to $260.00 and gave the company a “neutral” rating in a research note on Thursday, August 13th. Morgan Stanley raised their price target on shares of Cardinal Health from $265.00 to $286.00 and gave the company an “overweight” rating in a report on Friday, October 30th. Finally, TD Cowen boosted their price objective on shares of Cardinal Health from $275.00 to $280.00 and gave the stock a “buy” rating in a research report on Thursday, August 13th. Sixteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, Cardinal Health has an average rating of “Moderate Buy” and an average price target of $271.31.

Cardinal Health Profile

Cardinal Health, Inc is a healthcare services and products company that supports the distribution and delivery of pharmaceuticals, medical products and related services. The company serves hospitals, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Its Pharmaceutical and Specialty Solutions segment distributes branded, generic and specialty pharmaceuticals, as well as consumer health products, to pharmacies and healthcare institutions.